| Keynote Speaker Timothy Caulfield, Faculty of Law, University of Alberta Invited Speakers Honourable Ian Binnie, Lenczner Slaght LLP, Toronto Canada Honourable Mr. Justice Sir Richard Arnold, High Court Patents, England & Wales Honourable Judge Paul Michel, Former Chief Judge of the Court of Appeals of the U.S. Federal Circuit Jennifer Gordon, Baker Botts LLP, New York Malathi Lakshmikumaran, Lakshmikumaran & Sridharan Attorneys, New Delhi, India James Cherry, Freehills Patent & Trade Mark Attorneys, Melbourne, Australia Michelin Gravelle, Bereskin & Parr, Toronto, Canada Friederike Stolzenburg, Vossius & Partner, Munich, Germany Jan Witkowski, Cold Spring Harbor Laboratory Pavel Osten, Cold Spring Harbor Laboratory and Certerra, Inc. Katherine Strandburg, New York University School of Law Michele Wales, VP of Litigation and Intellectual Property, Human Genome Sciences, Rockville, Maryland John T. Aquino, Legal Editor, Life Sciences Law Industry Report, Bloomberg BNA Jennifer Elliott, Genentech, South San Francisco, California Ben Jackson, Myriad Genetics, Salt Lake City, Utah Blair Taylor, Roche Medical Diagnostics Warren Woessner, Schwegman Lundberg Woessner, Minneapolis, Minnesota Kathleen Determann, Genomic Health Inc., Redwood City, California Jeffrey Peterson, Target Discovery Inc., Palo Alto, California David Resnik, NIH National Institute of Enviromental Health Sciences Arti K. Rai, Duke Law School, Duke Institute for Genome Sciences & Policy Richard Gold, Faculty of Law, McGill University Hans Sauer, Biotechnology Industry Organization, Washington, D.C. Daniel Kevles, Department of History, Yale University
|
